Biosimilars Added To FDA’s Citizen Petition Certification Program
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency estimates it will receive 26 certifications for citizen petitions that could potentially delay biosimilar or generic applications and one certification for a petition for stay of agency action.